1)Bay-Richter C, Linderholm KR, Lim CK, et al:A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 43:110-117, 2015
2)Bryleva EY, Brundin L:Kynurenine pathway metabolites and suicidality. Neuropharmacology 112(Pt B):324-330, 2017
3)Busse M, Busse S, Myint AM, et al:Decreased quinolinic acid in the hippocampus of depressive patients:evidence for local anti-inflammatory and neuroprotective responses? Eur Arch Psychiatry Clin Neurosci 265:321-329, 2015
4)Dantzer R, O' Connor JC, Freund GG, et al:From inflammation to sickness and depression:when the immune system subjugates the brain. Nat Rev Neurosci 9:46-56, 2008
5)Dantzer R:Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression:Preclinical Approaches. Curr Top Behav Neurosci 31:117-138, 2017
6)Fakhoury M:Revisiting the Serotonin Hypothesis:Implications for Major Depressive Disorders. Mol Neurobiol 53:2778-2786, 2016
7)Graff EC, Fang H, Wanders D, et al:Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2. Metabolism 65:102-113, 2016
8)Iwata M, Ota KT, Li XY, et al:Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor. Biol Psychiatry 80:12-22, 2016
9)Kato TA, Shinfuku N, Fujisawa D, et al:Introducing the concept of modern depression in Japan;an international case vignette survey. J Affect Disord 135:66-76, 2011
10)Kato TA, Monji A, Mizoguchi Y, et al:Anti-Inflammatory properties of antipsychotics via microglia modulations:are antipsychotics a ‘fire extinguisher' in the brain of schizophrenia? Mini Rev Med Chem 11:565-574, 2011
11)加藤隆弘:ミクログリアの機能から見た統合失調症.精神科治療学 26:1571-1580, 2011
12)Kato TA, Shinfuku N, Sartorius N, et al:Are Japan's hikikomori and depression in young people spreading abroad? Lancet 378:1070, 2011
13)Kato TA, Hayakawa K, Monji A, et al:Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia. Front Integr Neurosci 7:53, 2013
14)Kato TA, Yamauchi Y, Horikawa H, et al:Neurotransmitters, psychotropic drugs and microglia:clinical implications for psychiatry. Curr Med Chem 20:331-344, 2013
15)加藤隆弘,扇谷昌宏,渡部幹,他:こころのミクログリア仮説解明に向けたトランスレーショナル研究.日本生物学的精神医学会誌 27:2-7, 2016
16)Kato TA, Hashimoto R, Hayakawa K, et al:Multidimensional anatomy of ‘modern type depression' in Japan:A proposal for a different diagnostic approach to depression beyond the DSM-5. Psychiatry Clin Neurosci 70:7-23, 2016
17)加藤隆弘:ミクログリア研究で精神分析学・精神病理学を再解釈する試み.日本生物学的精神医学会誌 27:151-157, 2016
18)加藤隆弘,早川宏平,佐藤美那,他:現代抑うつ症候群(現代うつ・新型うつ)に対する多軸的評価システムの構築:大学病院気分障害外来での取り組み紹介.精神科臨床サービス 16:183-191, 2016
19)加藤隆弘,桑野信貴,神庭重信:「現代抑うつ症候群(新型うつ・現代うつ)」は閾値下うつ,あるいは,適応障害か? 精神医学的知見に鑑みて.ストレス科学 32:63-73, 2017
20)Kato TA, Kanba S:Modern-Type Depression as an “Adjustment” Disorder in Japan:The Intersection of Collectivistic Society Encountering an Individualistic Performance-Based System. Am J Psychiatry 174:1051-1053, 2017
21)Monji A, Kato T, Kanba S:Cytokines and schizophrenia:Microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 63:257-265, 2009
22)Muller N, Schwarz MJ:The immune-mediated alteration of serotonin and glutamate:towards an integrated view of depression. Mol Psychiatry 12:988-1000, 2007
23)Muller N, Myint AM, Schwarz MJ:The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. Dialogues Clin Neurosci 11:319-332, 2009
24)Offermanns S, Colletti SL, Lovenberg TW, et al:International Union of Basic and Clinical Pharmacology. LXXXII:Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors(GPR81, GPR109A, and GPR109B). Pharmacol Rev 63:269-290, 2011
25)Owens MJ, Nemeroff CB:Role of serotonin in the pathophysiology of depression:focus on the serotonin transporter. Clin Chem 40:288-295, 1994
26)Rahman M, Muhammad S, Khan MA, et al:The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 5:3944, 2014
27)Sada N, Lee S, Katsu T, et al:Epilepsy treatment. Targeting LDH enzymes with a stiripentol analog to treat epilepsy. Science 347:1362-1367, 2015
28)Setiawan E, Wilson AA, Mizrahi R, et al:Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72:268-275, 2015
29)Setoyama D, Kato TA, Hashimoto R, et al:Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis. PLoS One 11:e0165267, 2016
30)Steiner J, Walter M, Gos T, et al:Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus:evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 8:94, 2011
31)Yamanashi T, Iwata M, Kamiya N, et al:Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses. Sci Rep 7:7677, 2017
32)Youm YH, Nguyen KY, Grant RW, et al:The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21:263-269, 2015